Get the Stockscreener App
11.37
0.44%
-0.05
After Hours:
11.29
-0.08
-0.70%
Ginkgo Bioworks Holdings Inc stock is traded at $11.37, with a volume of 1.55M.
It is down -0.44% in the last 24 hours and down -4.77% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$11.42
Open:
$11.47
24h Volume:
1.55M
Relative Volume:
0.95
Market Cap:
$535.41M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-0.8753
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
+13.59%
1M Performance:
-4.77%
6M Performance:
+52.01%
1Y Performance:
+36.82%
1-Day Range:
$11.10
$11.68
1-Week Range:
$9.87
$11.89
52-Week Range:
$5.00
$16.85
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
11.37 | 676.06M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
Breakout Zone: Is Ginkgo Bioworks Holdings Inc a cyclical or defensive stockPrice Action & Scalable Portfolio Growth Ideas - khodrobank.com
Aug Weekly: How cyclical is Ginkgo Bioworks Holdings Incs revenue streamMarket Sentiment Review & Fast Exit and Entry Trade Guides - khodrobank.com
Goldman Sachs Group Inc. Acquires 139,126 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Treasury Yields: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandWeekly Trade Recap & Verified Entry Point Detection - khodrobank.com
Aug Gainers: Can Ginkgo Bioworks Holdings Inc maintain sales growth2025 Short Interest & AI Driven Price Predictions - khodrobank.com
Aug Sentiment: Is Ginkgo Bioworks Holdings Inc stock forming a cup and handleQuarterly Trade Report & Community Verified Watchlist Alerts - khodrobank.com
Market Overview: Can Ginkgo Bioworks Holdings Inc. sustain earnings growthQuarterly Portfolio Summary & Verified Technical Trade Signals - khodrobank.com
Ginkgo Bioworks (NYSE:DNA) Trading Down 3.5%What's Next? - MarketBeat
Aug Rallies: How cyclical is Ginkgo Bioworks Holdings Incs revenue stream2025 Price Action Summary & AI Powered Market Entry Ideas - khodrobank.com
Growth Value: What are the future prospects of Ginkgo Bioworks Holdings IncJuly 2025 Catalysts & Expert Curated Trade Setups - khodrobank.com
Dividend Watch: Can Ginkgo Bioworks Holdings Inc maintain sales growthJuly 2025 Short Interest & Risk Adjusted Buy and Sell Alerts - khodrobank.com
Take Profit: Does Ginkgo Bioworks Holdings Inc have strong fundamentalsPortfolio Performance Report & Momentum Based Trading Signals - khodrobank.com
Fed Meeting: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandPortfolio Update Summary & Safe Entry Zone Identification - khodrobank.com
Risks Report: Will Edible Garden AG Incorporated Equity Warrant outperform small cap indexesJuly 2025 Big Picture & Short-Term High Return Strategies - خودرو بانک
Inflation Data: Is Ginkgo Bioworks Holdings Inc. a strong candidate for buy and hold2025 Market WrapUp & AI Powered Buy/Sell Recommendations - khodrobank.com
Risk Off: What dividend growth rate does Ginkgo Bioworks Holdings Inc offerRecession Risk & Fast Gain Stock Tips - خودرو بانک
Insider Sell: How cyclical is Ginkgo Bioworks Holdings Incs revenue streamSwing Trade & Detailed Earnings Play Alerts - خودرو بانک
Aug Spikes: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingQuarterly Performance Summary & Free High Return Stock Watch Alerts - khodrobank.com
Panic Selling: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demandJuly 2025 Volume & Weekly Return Optimization Plans - khodrobank.com
Loss Report: Does AdaptHealth Corp stock have upside surprise potentialMarket Activity Report & Scalable Portfolio Growth Methods - خودرو بانک
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
Ginkgo Bioworks Enters Sales Agreement for Stock Offering - MSN
This Ginkgo Bioworks Holdings Insider Reduced Their Stake By 45% - simplywall.st
American Century Companies Inc. Makes New Investment in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Cubist Systematic Strategies LLC Buys 287,221 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Invesco Ltd. Grows Stock Position in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks enters into $100M equity sales deal - MSN
EcoR1 Capital LLC Sells 281,016 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks Holdings Inc. Chart Enters High Volatility ZoneTake Profit & High Yield Equity Trading Tips - classian.co.kr
Latham & Watkins Advises on Ginkgo Bioworks Holdings, Inc.’s US$100 Million At-the-Market Equity Offering Program - Latham & Watkins LLP
Published on: 2025-09-08 17:17:45 - beatles.ru
Ginkgo Bioworks Holdings, Inc. $DNA Stock Holdings Increased by PDT Partners LLC - MarketBeat
Institutional Investors in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) See US$84m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Will breakout in Ginkgo Bioworks Holdings Inc. lead to full recoveryPortfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
Pattern recognition hints at Ginkgo Bioworks Holdings Inc. upsideTrade Volume Report & Community Consensus Stock Picks - Newser
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 8.5%Should You Sell? - MarketBeat
How moving averages guide Ginkgo Bioworks Holdings Inc. tradingQuarterly Portfolio Report & Reliable Price Breakout Alerts - Newser
Should you avoid Ginkgo Bioworks Holdings Inc. stock right nowJuly 2025 Technicals & Community Verified Trade Signals - خودرو بانک
Will Ginkgo Bioworks Holdings Inc. stock go up soonJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
Developing predictive dashboards with Ginkgo Bioworks Holdings Inc. data2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Will Ginkgo Bioworks Holdings Inc. stock recover after recent dropJuly 2025 Summary & Daily Stock Trend Reports - Newser
Detecting price anomalies in Ginkgo Bioworks Holdings Inc. with AIJuly 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium - MarketScreener
Major AI Drug Discovery Initiative: Ginkgo Bioworks Creates First-Ever Antibody Development Consortium - Stock Titan
Is Ginkgo Bioworks Holdings Inc. stock reversal real or fake2025 Market Overview & Fast Moving Stock Trade Plans - Newser
Predicting Ginkgo Bioworks Holdings Inc. trend using moving averagesJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Combining price and volume data for Ginkgo Bioworks Holdings Inc.Market Risk Report & AI Powered Market Trend Analysis - Newser
Is Ginkgo Bioworks Holdings Inc. a candidate for recovery playTreasury Yields & AI Powered Trade Plan Recommendations - Newser
Visualizing Ginkgo Bioworks Holdings Inc. stock with heatmaps2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Is a relief rally coming for Ginkgo Bioworks Holdings Inc. holdersWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):